Tenaya Therapeutics Inc. (TNYA)
undefined
undefined%
At close: undefined
2.78
1.14%
Pre-market Dec 16, 2024, 04:37 AM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19
Net Income -124.08M -123.67M -72.72M -38.40M -26.23M
Depreciation & Amortization 8.69M 6.47M 2.96M 2.48M 1.99M
Stock-Based Compensation 15.31M 11.47M 2.95M 741.00K 414.00K
Other Working Capital -2.37M -2.51M -3.86M -376.00K -647.00K
Other Non-Cash Items 3.66M 2.16M 1.06M -75.00K 64.00K
Deferred Income Tax - - 192.00K 33.00K -82.00K
Change in Working Capital -5.65M -849.00K 4.74M -234.00K -250.00K
Operating Cash Flow -102.07M -104.42M -60.81M -35.45M -24.10M
Capital Expenditures -1.24M -20.63M -25.12M -9.76M -2.93M
Acquisitions - - - - 2.66K
Purchase of Investments -56.64M -140.48M -213.44M - -12.66M
Sales Maturities Of Investments 106.62M 244.75M - 2.75M 10.00M
Other Investing Acitivies -25.00K 8.00K -213.44K 2.75K -2.66K
Investing Cash Flow 48.72M 83.65M -238.56M -7.01M -5.58M
Debt Repayment - - - - -
Common Stock Repurchased - - -13.00K -1K -3.00K
Dividend Paid - - - - -
Other Financial Acitivies 181.00K 380.00K 20.44M 147.27M 30.51M
Financial Cash Flow 4.05M 77.77M 208.97M 147.27M 30.51M
Net Cash Flow -49.31M 56.99M -90.41M 104.81M 832.00K
Free Cash Flow -103.31M -125.05M -85.93M -45.21M -27.02M